Skip to content

An observational study to find the incidence and risk factors of central venous catheter associated deep vein thrombosis in ICU patients

A Prospective Observational Study Of The Incidence and Risk Factors Of Catheter Associated Deep Vein Thrombosis in ICU Patients - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077013
Enrollment
120
Registered
2024-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I824- Acute embolism and thrombosis of deep veins of lower extremity Health Condition 2: I82C- Embolism and thrombosis of internal jugular vein

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Artemis Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with IJV or Femoral central venous catheter placement (Central venous line, dialysis catheter, introducer sheath)

Exclusion criteria

Exclusion criteria: 1) Patient refusal to participate in the study 2) Patients who are less than 18 years old 3) Discharge / LAMA/ demise before 72 hours 4) Pre-existing haematological thrombotic disorder 5) Patients with active diagnosis of DVT/ pulmonary embolism 6) Any reason wherein USG examination not possible 7) Repeat catheter insertion in the same vein.

Design outcomes

Primary

MeasureTime frame
incidence and risk factors of central venous catheter associated deep vein thrombosis.Timepoint: incidence of thrombosis will be assessed at day 3,5,7,10 and 15

Secondary

MeasureTime frame
1.incidence of patient related risk factors. 2.incidence of catheter related risk factors. 3. Occurrence of deep vein thrombosis with respect to time frame 4.incidence of deep vein thrombosis with respect to thromboprophylaxis. 5. Proportion of symptomatic & asymptomatic cases Timepoint: 1.incidence of patient & catheter related risk factors will be assessed after 28 days or till patient stay in hospital 3.Occurrence of deep vein thrombosis with respect to time frame on day 3,5,7,10,15 & 28 4.incidence of deep vein thrombosis with respect to thromboprophylaxis on day 3,5,7,10,15 5.Proportion of symptomatic & asymptomatic cases will be assessed till day 28 of hospital stay/discharge/demise

Countries

India

Contacts

Public ContactAnjusha TV

Artemis hospital

anjushaashokan93@gmail.com8848225926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026